UNM
68
7
WFC
72
-2
CFG
89
-4
AMGN
34
-4
BAX
39
-2
LNC
66
-2
CB
67
2
DAL
68
-2
C
79
-2
CMG
57
-6
WAT
59
10
GPC
47
-3
DUK
57
2
GS
72
-3
FSLR
55
-3
CLX
55
3
VMC
56
-3
AAL
45
-3
TAP
37
2
UPS
37
-3
UNM
68
7
WFC
72
-2
CFG
89
-4
AMGN
34
-4
BAX
39
-2
LNC
66
-2
CB
67
2
DAL
68
-2
C
79
-2
CMG
57
-6
WAT
59
10
GPC
47
-3
DUK
57
2
GS
72
-3
FSLR
55
-3
CLX
55
3
VMC
56
-3
AAL
45
-3
TAP
37
2
UPS
37
-3
Financhill
Back

ProShares Short 20+ Yr Treasury Vs. Monopar Therapeutics, Inc. Industry Stock Comparison

Buy
62

TBF
ProShares Short 20+ Yr Treasury

Last Price:
$23.87
Seasonality Move:
-0.66%
Sell
36

MNPR
Monopar Therapeutics, Inc.

Last Price:
$65.53
Seasonality Move:
10.04%
Buy
62
ProShares Short 20+ Yr Treasury (TBF) is a Buy

Is ProShares Short 20+ Yr Treasury a Buy, Sell or Hold?

  • The current ProShares Short 20+ Yr Treasury [TBF] share price is $23.87. The Score for TBF is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • TBF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Monopar Therapeutics, Inc. [MNPR] share price is $65.57. The Score for MNPR is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TBF Stock Price Chart

What is ProShares Short 20+ Yr Treasury's stock price today?

  • The ProShares Short 20+ Yr Treasury share price today is $23.87
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TBF is experiencing selling pressure, which indicates risk of future bearish movement.

MNPR Stock Price Chart

What is Monopar Therapeutics, Inc.'s stock price today?

  • The Monopar Therapeutics, Inc. share price today is $65.57
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing selling pressure, which indicates risk of future bearish movement.

TBF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.55 Buy
Relative Strength Index (14 RSI): 46.46 Sell
Chaikin Money Flow: -37054 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (23.71 - 24.19) Sell
Bollinger Bands (100): (23.46 - 24.34) Sell

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.64 Sell
Relative Strength Index (14 RSI): 34.78 Sell
Chaikin Money Flow: -475908 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (69.1 - 84.46) Sell
Bollinger Bands (100): (47.85 - 89.77) Sell

TBF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.07 Sell
20-day SMA: 24.03 Sell
50-day SMA: 23.71 Buy
200-day SMA: 24.2 Sell
8-day EMA: 19.87 Buy
20-day EMA: 12.11 Buy
50-day EMA: 5.87 Buy
200-day EMA: 1.63 Buy

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 68.61 Sell
20-day SMA: 73.66 Sell
50-day SMA: 79.24 Sell
200-day SMA: 53.33 Buy
8-day EMA: 69.45 Sell
20-day EMA: 73.2 Sell
50-day EMA: 75.42 Sell
200-day EMA: 57.3 Buy

ProShares Short 20+ Yr Treasury Earnings Growth & TBF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

ProShares Short 20+ Yr Treasury Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):